ES2055529T3 - Nuevos derivados de piridina y procedimientos para su sintesis. - Google Patents

Nuevos derivados de piridina y procedimientos para su sintesis.

Info

Publication number
ES2055529T3
ES2055529T3 ES91301571T ES91301571T ES2055529T3 ES 2055529 T3 ES2055529 T3 ES 2055529T3 ES 91301571 T ES91301571 T ES 91301571T ES 91301571 T ES91301571 T ES 91301571T ES 2055529 T3 ES2055529 T3 ES 2055529T3
Authority
ES
Spain
Prior art keywords
procedures
synthesis
new
piridine derivatives
piridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91301571T
Other languages
English (en)
Inventor
Charles W Murtiashaw
George J Quallich
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Application granted granted Critical
Publication of ES2055529T3 publication Critical patent/ES2055529T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/64—One oxygen atom attached in position 2 or 6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)

Abstract

ESTA INVENCION SE REFIERE A UN PROCESO E INTERMEDIARIOS PARA LA PREPARACION DE AZOLONES-HETERO-SPIRO. LOS ULTIMOS COMPUESTOS SON UTILES COMO INHIBIDORES DE REDUCTASA ALDOSA.
ES91301571T 1990-03-07 1991-02-27 Nuevos derivados de piridina y procedimientos para su sintesis. Expired - Lifetime ES2055529T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/490,906 US5068333A (en) 1990-03-07 1990-03-07 6-chloro-3,4-dihydro-pyrano [2,3-b]pyridines having the R configuration

Publications (1)

Publication Number Publication Date
ES2055529T3 true ES2055529T3 (es) 1994-08-16

Family

ID=23949994

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91301571T Expired - Lifetime ES2055529T3 (es) 1990-03-07 1991-02-27 Nuevos derivados de piridina y procedimientos para su sintesis.

Country Status (10)

Country Link
US (2) US5068333A (es)
EP (1) EP0445950B1 (es)
JP (1) JPH0586031A (es)
AT (1) ATE106871T1 (es)
CA (1) CA2037590A1 (es)
DE (1) DE69102315T2 (es)
ES (1) ES2055529T3 (es)
FI (1) FI911124A (es)
IE (1) IE910740A1 (es)
PT (1) PT96948A (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11257361A (ja) 1998-01-08 1999-09-21 Nippon Seiko Kk 転がり軸受の密封装置
CN103664765A (zh) * 2013-12-06 2014-03-26 常熟市联创化学有限公司 一种2-氨基-3-溴吡啶的制备方法
CN105061300B (zh) * 2015-08-31 2018-02-16 南京红太阳生物化学有限责任公司 一种氯代吡啶及其衍生物的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4176185A (en) * 1979-01-22 1979-11-27 Pfizer Inc. Spiro-quinolylhydantoins
FR2455046A1 (fr) * 1979-04-25 1980-11-21 Science Union & Cie Nouvelles hydantoines, leur procede de preparation et leur emploi comme medicament
US4287347A (en) * 1980-05-12 1981-09-01 Ciba-Geigy Corporation Process for producing 2,3,5-trichloropyridine
US4510148A (en) * 1982-06-12 1985-04-09 Pfizer Inc. 2-Heterocyclic-1,3-bis(1H-1,2,4-triazol-1-yl)-propan-2-ols as antifungal agents
CA1217774A (en) * 1983-09-06 1987-02-10 Richard L. Burson Halopyridines
MX12896A (es) * 1987-09-04 1993-06-01 Pfizer Procedimiento para preparar un compuesto de espiro-heteroazolonas
US4980357A (en) * 1990-03-01 1990-12-25 Pfizer Inc. Azolidinedione derivatives

Also Published As

Publication number Publication date
US5068333A (en) 1991-11-26
US5336771A (en) 1994-08-09
ATE106871T1 (de) 1994-06-15
JPH0586031A (ja) 1993-04-06
IE910740A1 (en) 1991-09-11
EP0445950B1 (en) 1994-06-08
FI911124A0 (fi) 1991-03-06
EP0445950A1 (en) 1991-09-11
DE69102315T2 (de) 1994-09-15
CA2037590A1 (en) 1991-09-08
PT96948A (pt) 1991-10-31
FI911124A (fi) 1991-09-08
DE69102315D1 (de) 1994-07-14

Similar Documents

Publication Publication Date Title
FI914905A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten merkaptoasetyyliamidopyrrolo- ja -pyridobentsatsepiinijohdannaisten valmistamiseksi
MX9200817A (es) Derivados de piranil cianoguanidina y proceso para su preparacion.
NO902394L (no) Fremgangsmaate for fremstilling av pyranyl-cyanoguanidin-derivater.
AU3025689A (en) Substituted 1,2,4-triazinediones, processes for their preparation and their use
MX9101767A (es) Derivados de heteroaroilo y procedimiento para su obtencion
ES2134910T3 (es) Sintesis de bisindolilmaleimidas.
ES496038A0 (es) Procedimiento para la obtencion de 2-hidroxialquil-3,4,5- trihidroxi-piperidinas
PT80489B (fr) Procede de preparation de nouveaux derives heterocycliques utilisables notamment comme innibiteurs de l'aldose reductase
DK0424350T3 (da) Derivater af 1,4-dideoxy-1,4-imino-D-mannitol
ES2055529T3 (es) Nuevos derivados de piridina y procedimientos para su sintesis.
DE69703115D1 (de) Zwischenprodukte um 2-imidazolin-5onederivate herzustellen.
MX9305467A (es) Compuestos intermedios, quirales, de quinolona y procedimiento para su preparacion.
ES2120483T3 (es) Alcoholes benzilo y benzhidrilo.
ES2055416T3 (es) Derivados de fenilsulfona.
DE69012845T2 (de) Exo-3'-4'-O-benzyliden-3"-demethylchartreusin und seine Salze.
ES2130154T3 (es) Gliceraldehido-3-pentanido y procedimiento para su preparacion.
DE69025817D1 (de) 3-Keto-HMG-CoA Reduktase-Inhibitoren
ES2039270T3 (es) Derivados de gamma-l-glutamil-4-nitroanilida y procedimiento para determinar actividad de gamma-gtp utilizandolos.
FI944967A (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 445950

Country of ref document: ES